본문으로 바로가기 주메뉴 바로가기

About KBIOHealth

Our Story

2010s~

2024

  • 04

    Start Cell Characterization Support Center

2022

  • 04

    Selected as 'Excellent Institution' in the public institution customer satisfaction survey for 2 consecutive years
    * Total 245 institutions

2021

  • 05

    Inauguration of the KBIO Health 4th Chairman, Sang-hoon Cha

  • 10

    Setting up Office of Regulatory Science

  • 12

    Acquired budget for Cell Line Characterization infrastructure
    * scheduled to be operational in 2024

2020

  • Mar

    Designation of an institution conducting the analysis of clinical trial samples (followed by GCLP)

2019

  • 01

    Classified and designated as · R&D Institute

  • 03

    Opened Cheongju Biomedical Big Data Center

  • 06

    Acquired “Excellent Grade (A)” in the public institution management performance evaluation of the Ministry of Health and Welfare Designated as a non-clinical testing institution (GLP) for medical devices by the Ministry of Food and Drug Safety (In vitro test)

  • 06

    Acquired “Excellent Grade (A)” in the public institution management performance evaluation of the Ministry of Health and Welfare Designated as a non-clinical testing institution (GLP) for medical devices by the Ministry of Food and Drug Safety (In vitro test)

  • 07

    Opened Korea Bio Human Resource Development Center

  • 07

    Designation of an institution conducting non-clinical studies for medical device from KFDA

2018

  • 02

    3rd Chairman Gusun Park was inaugurated

2015

  • 01

    Osong Biomedical Innovation Foundation was appointed as public institution

2014

  • 12

    2nd Chairman Kyung Sun was inaugurated

2013

  • 11

    Construction of 4 Core Research Support Facilities Completed

2011

  • 03

    Inauguration of the first chief director of Osong Hi-tech Medical Industry Promotion Foundation

  • 04

    3 center chiefs(scheduled to nominate a chief of Hi-tech Medical Apparatus Center in July) nominated

2010

  • 01

    The composition plan for a hi-tech medical complex composition plan(6th committee) deliberated on and decided upon

  • 12

    A convention on the creation of the foundation and a general establishment meeting (selected a proxy chief director) held

  • 12

    Approval for establishing a corporation(Ministry of Education, Science and Technology, Ministry of Knowledge Economy, Ministry of Health & Welfare) received

  • 12

    Registered as a corporation and official seal(Chungju District Court) announced

  • 12

    Corporate director(14 persons - Ministry of Health & Welfare) nominated

2000s

2009

  • 08

    Osong designated the optimal location for a hi-tech medical complex

  • 08

    A team to deal with establishment preparation issues related to the foundation (10th August 2009)(dissolved on 31st December 2010) convened

  • 11

    Osong designated as a hi-tech medical complex site

2008

  • 03

    A "special law regarding the designation and support of a hi-tech medical complex“ established

  • 11

    A hi-tech medical complex committee(chairman: prime minister) instituted

2005

  • 10

    1st medical industry performance enhancement committee(chairman: prime minister) instituted

    The direction for enhancing the performance of the medical industry performance established and the policy for establishing a hi-tech medical complex formulated